Drug Discovery
Dana-Farber appoints new head for drug discovery and research
Scott A. Armstrong, MD, PhD, has been named senior vice president for drug discovery and chief research strategy officer at Dana-Farber Cancer Institute, according to a press release.
Penicillin: An accidental discovery changed the course of medicine
This year marks the 80th anniversary of the discovery of penicillin, the first naturally occurring antibiotic drug discovered and used therapeutically.
Astrocyte Pharmaceuticals gets $6M to advance novel brain injury therapeutic
A Boston-area clinical stage drug discovery and development company announced $6 million in pre-Series B bridge financing to advance a novel cerebroprotectant therapeutic intended to treat a broad range of acute brain injuries.
Family of Estée Lauder donates $200M to Alzheimer’s research
The descendants of Estée Lauder donated $200 million to the Alzheimer’s Drug Discovery Foundation to help prevent, diagnose, treat and cure the disease, according to a press release.
Minnesota sees 400% increase in illicit fentanyl since 2019
Illicit fentanyl positivity in patient samples from substance use disorder treatment practices in Minnesota increased by 400% during the first half of 2022 compared with 2019, according to a press release from a drug testing laboratory.
Quanterix, Alzheimer’s Drug Discovery Foundation partner to accelerate AD detection test
Quanterix Corp. announced it has partnered with the Alzheimer’s Drug Discovery Foundation to accelerate the development of a multi-analyte plasma test for early detection of Alzheimer’s disease.
VIDEO: Panel discusses roadblocks in cancer drug development
In this video, Lillian L. Siu, MD, FRCPC, discussed a panel discussion at 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics on the topic of in drug development roadblocks.